Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Hepatitis B Virus Related Hepatocellular Carcinoma Clinical Trials

2 recruiting trials for Hepatitis B Virus Related Hepatocellular Carcinoma. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
1
Sponsors

Recruiting Trials

RECRUITINGPhase 1NCT06617000

A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related

This is a Phase I clinical study aimed to assess the safety, tolerability, and efficacy of SCG101 monotherapy for patients with HBV-HCC.

Sponsor: SCG Cell Therapy Pte. Ltd.Enrolling: 387 locations
RECRUITINGPhase 1 / Phase 2NCT05417932

A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma

This Phase 1/ 2a study is a multicenter study to evaluate the safety, tolerability and efficacy of SCG101 in subjects with hepatitis B virus-related hepatocellular carcinoma

Sponsor: SCG Cell Therapy Pte. Ltd.Enrolling: 466 locations